OncoTherapy Science Inc represents values of innovation, integrity, and commitment to advancing cancer treatments. The company's corporate philosophy revolves around conducting groundbreaking research to develop effective therapies for oncology patients. With a focus on precision medicine, OncoTherapy Science Inc aims to deliver personalized and targeted treatments for individuals battling cancer. Their dedication to scientific excellence, collaboration with key stakeholders, and patient-centric approach sets them apart in the field of oncology. OncoTherapy Science Inc's commitment to improving patient outcomes and revolutionizing cancer care aligns with their vision of becoming a global leader in precision oncology.

OncoTherapy Science Inc is primarily present in Japan.

OncoTherapy Science Inc, a leading biotechnology company, has achieved several significant milestones in its journey. The company's dedication to cutting-edge research and innovation has resulted in remarkable achievements. OncoTherapy Science Inc has successfully developed and commercialized groundbreaking therapies for various types of cancers, revolutionizing the treatment landscape. Moreover, the company has received multiple accolades for its exceptional contributions to the field of oncology. OncoTherapy Science Inc's relentless pursuit of excellence has positioned it as a key player in the fight against cancer, making it a trusted name in the industry. With numerous achievements under its belt, OncoTherapy Science Inc continues to pave the way for advancements in cancer treatment.

OncoTherapy Science Inc is a leading biotechnology company specializing in innovative cancer therapies. With a rich history spanning several successful years, OncoTherapy Science Inc has consistently demonstrated its commitment to revolutionizing cancer treatment through cutting-edge research and development. The company has a strong background in targeted therapies, utilizing advanced techniques to understand and combat the complex mechanisms of cancer. OncoTherapy Science Inc prioritizes patient-centric approaches, seeking to improve clinical outcomes and ultimately save lives. Their dedicated team of scientists and researchers are relentlessly working towards discovering breakthrough treatments for various types of cancer, cementing their position as a trusted leader in the field of oncology.

The main competitors of OncoTherapy Science Inc in the market include pharmaceutical companies such as Pfizer, Merck & Co., and Novartis.

OncoTherapy Science Inc is primarily active in the biotechnology industry.

The business model of OncoTherapy Science Inc revolves around developing cutting-edge therapies for cancer treatment. The company focuses on leveraging its innovative technologies and expertise in molecular biology to discover and develop novel drugs targeting cancer cells. OncoTherapy Science Inc aims to improve patient outcomes by advancing precision medicine through personalized therapies. By analyzing the genetic makeup of tumor cells, the company identifies specific targets and develops therapeutics to inhibit their growth. With a strong emphasis on research and development, OncoTherapy Science Inc strives to bring breakthrough treatments to market, offering hope to cancer patients worldwide.

OncoTherapy Science의 P/E 비율은 -6.61입니다.

OncoTherapy Science의 P/S 비율은 13.95입니다.

OncoTherapy Science에 대한 AlleAktien 품질 점수는 3/10입니다.

OncoTherapy Science 매출은 610.12 백만 JPY입니다.

OncoTherapy Science 이익은 -1.29 조. JPY입니다.

OncoTherapy Science Inc. is a leading biopharmaceutical company focused on the development of innovative cancer therapies. It offers a comprehensive portfolio of therapeutics and diagnostics to improve the treatment and cure of cancer patients worldwide. The company is divided into different divisions to enable effective development of cancer therapies, including research and development, production, marketing, and distribution of cancer drugs. The research and development department of OncoTherapy Science Inc. consists of a team of scientists and researchers who focus on identifying new therapeutic targets and developing innovative therapeutics. The research department has already made significant advances in the field of personalized medicine. OncoTherapy Science Inc. provides a wide range of products to offer better therapy options for cancer patients, including innovative antibody-based therapeutics, including immunotherapies, cytokines, antibody conjugates, mono- and polyclonal antibodies. The company also works on the development of diagnostics to enhance the effectiveness of therapy options, offering tests and diagnostic instruments that improve the accuracy of diagnosis and help patients choose the best possible therapy option. OncoTherapy Science Inc. also has a production department that utilizes modern technologies and automated production lines. The production facilities are set up according to the latest GMP standards to ensure that the products are of the highest quality and purity and comply with FDA regulations. The company markets and distributes its products worldwide through a network of partners and distributors. It has branches in different countries and collaborations with leading research institutions and universities around the world to support its research and development. In summary, OncoTherapy Science Inc. is a company focused on the research, development, and marketing of cancer therapeutics and diagnostics. It aims to provide better treatment options for cancer patients worldwide and has already made significant progress. With its wide range of innovative products, modern production facility, and strong research and development program, OncoTherapy Science Inc. is a leading company in cancer research and therapy.

OncoTherapy Science은(는) 연간 번의 배당을 통해 0 JPY의 배당금을 지급합니다.

OncoTherapy Science의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

OncoTherapy Science의 ISIN은 JP3202150003입니다.

OncoTherapy Science의 WKN은 726692입니다.

OncoTherapy Science의 티커는 4564.T입니다.

지난 12개월 동안 OncoTherapy Science은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 OncoTherapy Science은(는) 0 JPY의 배당금을 지급할 것으로 예상됩니다.

OncoTherapy Science의 현재 배당 수익률은 입니다.

OncoTherapy Science은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

OncoTherapy Science은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 JPY의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

OncoTherapy Science은 '건강' 섹터에 속합니다.

OncoTherapy Science의 마지막 배당금을 0 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 OncoTherapy Science는 0 JPY를 배당금으로 지급했습니다.

OncoTherapy Science의 배당금은 JPY에 지급됩니다.